Evidence map›Paper›PMID 27924150›Full record

ArticleBiotechnology for biofuels2016

Increasing n-butanol production with

Virginia Schadeweg, Eckhard Boles

Open access · goldAbstract read
In one paragraph

Article in Biotechnology for biofuels, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. A comparative analysis of NADPH supply strategies inMetabolic engineering communications · 2024
    Article
  3. Review
  4. The response mechanism analysis ofFrontiers in microbiology · 2024
    Article
  5. Advances inJournal of fungi (Basel, Switzerland) · 2023
    Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Glucose/Xylose Co-FermentingFrontiers in bioengineering and biotechnology · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Virginia SchadewegInstitute of Molecular Biosciences, Goethe-University Frankfurt, Max-von-Laue Str.9, 60438 Frankfurt am Main, Germany.
Eckhard BolesInstitute of Molecular Biosciences, Goethe-University Frankfurt, Max-von-Laue Str.9, 60438 Frankfurt am Main, Germany.
Goethe University Frankfurt · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundn-Butanol can serve as an excellent gasoline substitute. Naturally, it is produced by some

resultsIn our recent work, we showed that n-butanol production via a clostridial acetoacetyl-CoA-derived pathway in engineered yeast was limited by the availability of coenzyme A (CoA) and cytosolic acetyl-CoA. Increasing their levels resulted in a strain producing up to 130 mg/L n-butanol under anaerobic conditions. Here, we show that under aerobic conditions. this strain can even produce up to 235 mg/L n-butanol probably due to a more efficient NADH re-oxidation. Nevertheless, expression of a bacterial water-forming NADH oxidase (nox) significantly reduced n-butanol production although it showed a positive effect on growth and glucose consumption. Screening for an improved version of an acetyl-CoA forming NAD

conclusionsBy further optimizing substrate supply and redox power in the form of coenzyme A, acetyl-CoA and NADH, n-butanol production with engineered yeast cells could be improved to levels never reached before with

Indexed as

Acetylating acetaldehyde dehydrogenaseAcetyl-CoACoenzyme An-ButanolPantothenateSaccharomycesTrans-2-enoyl-CoA reductase

Identifiers

PMID27924150
PMCPMC5123364
OpenAlexW2555473633

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.